John Rakesh MD - Chicago, Illinois 60637

John Rakesh MD is categorized under Noncommercial Research Organizations in Chicago, IL .

Business Name: John Rakesh MD
Contact Person: Rakesh John
Address: 5841 South Maryland Avenue # Mc6098, Chicago, Illinois 60637
Phone Number: (773) 702-1000
Website Address: uchicagokidshospital.org
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Noncommercial Research Organizations
SIC Code: 8733
NAICS Code: 6211110
Share This Business:
Related Businesses: American Research Institute In Turkey Inc - Chicago, IL 60637
Us Department Of Energy Chicago Office - Chicago, IL 60637
Us Department Of Energy Chicago Office - Chicago, IL 60637
Resource Opportunities Consulting - Chicago, IL 60637
Washington Park Consortium - Chicago, IL 60637
Choral Institute Of Chicago - Chicago, IL 60637
The University Of Chicago - Chicago, IL 60637
Beiser David G MD - Chicago, IL 60637
American Institute of Indian - Chicago, IL 60637
Institute For Mind & Biology - Chicago, IL 60637
Chicago Tumor Institute - Chicago, IL 60637
Univ Of Chicago Cancer Research Foundation - Chicago, IL 60637
Institute For Justice Clinic O - Chicago, IL 60637

The company John Rakesh MD provides B2B services in the form of Noncommercial Research Organizations from its single location in Illinois. 1 to 4 employees work for John Rakesh MD, and the business now earns $500.000 to $999.999 per annum.

John Rakesh MD was launched in 0 and is classified under SIC code and category 8733 , and NAICS number and grouping 6211110 . To contact John Rakesh MD, please call Rakesh John with the phone number (773) 702-1000 or visit its single location at 5841 South Maryland Avenue # Mc6098 in Chicago, Illinois 60637.

The location of the single location can also be found using the coordinates 41.788778,-87.60488. Read more details about this business on the webpage uchicagokidshospital.org or follow the company’s social media accounts, on Twitter and on Facebook.